Results 241 to 250 of about 8,274,484 (282)

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Impact of obesity on medically assisted reproductive treatments

Zygote, 2022
SummaryIncreasing evidence has demonstrated that obesity impairs female fertility and negatively affects human reproductive outcome following medically assisted reproduction (MAR) treatment. In the United States, 36.5% of women of reproductive age are obese.
Romualdo Sciorio   +3 more
openaire   +2 more sources

Prescriber Attitudes and Medication Assisted Treatment

West Virginia Medical Journal, 2022
INTRODUCTION Increases in opioid use disorder (OUD) and the consequences to communities across the United States have resulted in a call for an increase in buprenorphine-based medication-assisted treatment (MAT) options. As legislative efforts continue to expand, it is important to understand the provider viewpoint of any such expansion.
Courtney A. Hereford, MSPH, MSW   +4 more
openaire   +1 more source

Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder [PDF]

open access: yesJournal of Adolescent Health, 2017
The American Academy of Pediatrics recently recommended that pediatricians consider medication-assisted treatment (MAT) for adolescents with severe opioid use disorders. Little is known about adolescents' current use of MAT.We use data on episodes of specialty treatment for heroin or opioid use (n = 139,092) from a database of publicly funded treatment
Kenneth A Feder   +2 more
exaly   +3 more sources

Medication-Assisted Treatment With Methadone: Assessing the Evidence

Psychiatric Services, 2014
Detoxification followed by abstinence has shown little success in reducing illicit opioid use. Methadone maintenance treatment (MMT) helps individuals with an opioid use disorder abstain from or decrease use of illegal or nonmedical opiates. This review examined evidence for MMT's effectiveness.Authors reviewed meta-analyses, systematic reviews, and ...
Catherine Anne, Fullerton   +8 more
openaire   +2 more sources

Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence

Focus, 2014
Buprenorphine maintenance treatment (BMT) and methadone maintenance treatment (MMT) are pharmacological treatment programs for individuals with opioid use disorders. MMT is discussed in a companion article. This article describes BMT and reviews available research on its efficacy.Authors reviewed meta-analyses, systematic reviews, and individual ...
Cindy Parks, Thomas   +8 more
openaire   +2 more sources

An overview on medication-assisted treatment (MAT) for opioid dependence

Journal of Opioid Management, 2020
In this article, a broad overview of medication-assisted treatment (MAT) for opioid dependence has been provided. Significant benefits of commonly used drugs (buprenorphine, methadone, and naltrexone-based regimens) along with the therapeutic aspects of other available options are highlighted.
Tanay, Maiti   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy